Summary: A new systematic review identifies five primary ways microplastics can harm the brain, raising concerns that these particles may worsen or accelerate neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Microplastics can provoke inflammation, disrupt the blood–brain barrier, generate oxidative stress, impair mitochondrial function, and directly injure neurons.
Evidence from experimental and animal studies shows that microplastics can accumulate in brain tissue and interact with disease-related pathways—including beta-amyloid, tau and α-synuclein—linked to Alzheimer’s and Parkinson’s. While definitive proof of direct causation in humans is still lacking, reducing exposure to microplastics is a prudent step to potentially lower long-term neurological risk.
Key Facts
- Five primary harm pathways: Microplastics can activate immune responses, drive oxidative stress, weaken barrier defenses, impair mitochondrial energy production, and damage neurons.
- Brain accumulation: Studies indicate some microplastics can cross protective barriers and persist within neural tissue despite bodily clearance mechanisms.
- Disease relevance: These effects overlap with processes known to contribute to Alzheimer’s and Parkinson’s disease progression.
Source: University of Technology Sydney
Microplastics could be contributing to neurodegenerative disease progression, according to a new international review that maps five ways these particles can trigger inflammation and damage in the brain.
More than 57 million people worldwide currently live with dementia, and the number of Alzheimer’s and Parkinson’s cases is expected to rise substantially in coming decades. If microplastics worsen or hasten these conditions, the public health implications could be significant.
Associate Professor Kamal Dua, a pharmaceutical scientist at the University of Technology Sydney, has estimated that adults may consume roughly 250 grams of microplastics each year—an amount comparable to covering a dinner plate. Sources of exposure include contaminated seafood, table salt, processed foods, tea bags, plastic food containers and cutting boards, bottled drinks, food grown in polluted soils, and airborne fibres from carpet dust and synthetic clothing.
Common plastic types implicated include polyethylene, polypropylene, polystyrene and polyethylene terephthalate (PET). Although most microplastic particles are eventually cleared, a fraction resists breakdown and can accumulate in organs, including the brain.
The review, published in the journal Molecular and Cellular Biochemistry, was led by researchers at the University of Technology Sydney in collaboration with Auburn University. It synthesizes current experimental evidence to outline five main mechanisms by which microplastics may harm neural tissue: immune activation, oxidative stress, blood–brain barrier disruption, mitochondrial dysfunction and neuronal injury.
“Microplastics can weaken the blood–brain barrier and make it more permeable. Once that barrier is compromised, immune cells and inflammatory molecules gain access and can damage barrier cells further,” Associate Professor Dua explained.
He added that the body recognizes microplastics as foreign material, prompting microglia and other brain immune cells to respond. Environmental stressors and pollutants can compound this effect by increasing oxidative stress—an imbalance between reactive oxygen species and antioxidant defenses that damages lipids, proteins and DNA.
Microplastics appear to drive oxidative stress in two ways: by elevating levels of reactive oxygen species and by weakening the body’s antioxidant systems. The review also highlights how microplastics can impair mitochondrial function, lowering ATP production and starving neurons of the energy required for normal signaling and maintenance.
“These mechanisms do not act in isolation,” Associate Professor Dua noted. “They interact and amplify each other, increasing the potential for progressive neural damage.”
The authors describe specific links to Alzheimer’s pathology—such as heightened beta-amyloid and tau accumulation—and to Parkinson’s disease—through α-synuclein aggregation and injury to dopaminergic neurons. However, they stress that more targeted human studies are required to establish causal relationships and quantify risk.
First author Alexander Chi Wang Siu, a Master of Pharmacy student at UTS, is conducting laboratory work at Auburn University under Professor Murali Dhanasekaran, collaborating with UTS co-authors Associate Professor Dua, Dr Keshav Raj Paudel and Distinguished Professor Brian Oliver to better understand how microplastics influence brain cell function.
Previous research from UTS has investigated inhalation exposures and lung deposition of microplastics. Dr Paudel, a visiting scholar in the UTS Faculty of Engineering, continues to study how inhaled microplastics affect respiratory health.
Given the current evidence, the review authors recommend practical steps to reduce personal exposure to microplastics: avoid plastic food containers and cutting boards when possible, reduce use of tumble dryers, prefer natural fibres over synthetic textiles, and limit consumption of highly processed and packaged foods.
The researchers hope these findings will inform environmental and public health policies that aim to curb plastic production, improve waste management and limit the long-term health burden posed by pervasive environmental microplastics.
Key Questions Answered:
A: Microplastics can cross or weaken the blood–brain barrier, accumulate in neural tissue and trigger inflammatory and oxidative processes that damage brain cells.
A: Microplastic-induced processes overlap with established disease mechanisms: increased beta-amyloid and tau in Alzheimer’s, and α-synuclein aggregation with dopaminergic neuron injury in Parkinson’s.
A: Practical measures include minimizing use of plastic food containers and cutting boards, choosing natural fabrics, avoiding the clothes dryer, and eating fewer processed or packaged foods.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full by the editorial team.
- Additional context was provided by staff to clarify the research findings.
About this microplastics and neurology research news
Author: Leilah Schubert
Source: University of Technology Sydney
Contact: Leilah Schubert – University of Technology Sydney
Image: The image is credited to Neuroscience News
Original Research: Open access. “Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease” by Kamal Dua et al. (Molecular and Cellular Biochemistry). DOI: http://dx.doi.org/10.1007/s11010-025-05428-3
Abstract
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
The pervasive presence of microplastics (MPs) in the environment raises growing concerns about their potential impacts on human health. Estimates vary: some researchers have suggested adults may ingest the equivalent of a dinner plate of plastic annually, while others report exposure counts measured in tens of thousands of particles per year. Most particles are cleared, but because MPs are non-biodegradable, a fraction can persist and potentially cause long-term effects that remain incompletely understood.
This review examines emerging evidence linking chronic MP exposure to neurodegenerative processes, focusing on Alzheimer’s disease (AD) and Parkinson’s disease (PD). MPs appear capable of initiating neurotoxic pathways—activation of brain immune cells, oxidative stress, blood–brain barrier disruption, mitochondrial dysfunction and neuronal damage—that together may promote neuroinflammation and disease progression.
In relation to AD, the authors identify mechanisms including barrier breakdown, chronic inflammation, oxidative damage and reactive oxygen species generation, mitochondrial impairment, disrupted autophagy and proteostasis, and possible epigenetic effects. For PD, implicated pathways include barrier disruption, oxidative stress targeting dopaminergic neurons, mitochondrial dysfunction, microglial-driven neuroinflammation, α-synuclein aggregation and disturbances to the gut–brain axis.
The review concludes by calling for more targeted human studies to quantify neurological risk from chronic MP exposure and for stronger environmental policies to reduce plastic pollution and its potential long-term health consequences.